Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019

SELL
$25.78 - $39.77 $657,828 - $1.01 Million
-25,517 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$19.89 - $30.02 $422,761 - $638,075
-21,255 Reduced 45.44%
25,517 $641,000
Q2 2018

Aug 08, 2018

BUY
$7.93 - $15.79 $370,901 - $738,529
46,772 New
46,772 $572,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.